XML 265 R221.htm IDEA: XBRL DOCUMENT
v3.22.4

List of principal companies included in the scope of consolidation during 2022 - Summary of Principal Investments Accounted for Using the Equity Method (Details) | 12 Months Ended
--- | ---
Dec. 31, 2022
GlaxoSmithKline Consumer Healthcare, L.P. |
Disclosure of joint operations [line Items] |
Financial interest in principal investments accounted for using the equity method | 11.70%
Infraserv GmbH & Co. Höchst KG |
Disclosure of joint operations [line Items] |
Financial interest in principal investments accounted for using the equity method | 31.20%
Maphar |
Disclosure of joint operations [line Items] |
Financial interest in principal investments accounted for using the equity method | 48.30%
MCM Vaccine B.V. |
Disclosure of joint operations [line Items] |
Financial interest in principal investments accounted for using the equity method | 50.00%
MSP Vaccine Company (formerly MCM company) |
Disclosure of joint operations [line Items] |
Financial interest in principal investments accounted for using the equity method | 50.00%
EUROAPI |
Disclosure of joint operations [line Items] |
Financial interest in principal investments accounted for using the equity method | 30.10%

X
- Definition Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table. + References No definition available. + Details
Name: | ifrs-full_DisclosureOfJointOperationsLineItems
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The proportion of ownership interest in a joint operation attributable to the entity. [Refer: Joint operations [member]] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 12 -IssueDate 2021-01-01 -Paragraph 21 -Subparagraph a -Clause iv -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2021-en-r&anchor=para_21_a_iv&doctype=Standard -URIDate 2021-03-24 + Details
Name: | ifrs-full_ProportionOfOwnershipInterestInJointOperation
Namespace Prefix: | ifrs-full_
Data Type: | num:percentItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | ifrs-full_JointOperationsAxis=sny_GlaxoSmithKlineConsumerHealthcareLPMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_JointOperationsAxis=sny_InfraservGmbhAndCoHochstKGMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_JointOperationsAxis=sny_MapharMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_JointOperationsAxis=sny_MCMVaccineBVMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_JointOperationsAxis=sny_MSPVaccineCompanyMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_JointOperationsAxis=sny_EuroapiMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |